Teoxane SA

2 filings 1 distinct issuers Active 2025-01-06 → 2025-01-30

Track Record

Total filings

2 SCHEDULE

Distinct issuers

50% issuer diversity

Median stake

6.2%

6,550,800 avg shares

AI briefs cached

0/2

intent-classified filings

Filed	Form	Issuer	Stake	Shares	Intent
2025-01-30	SCHEDULE	Revance Therapeutics, Inc.	6.20%	6,550,800		view →
2025-01-06	SCHEDULE	Revance Therapeutics, Inc.	6.20%	6,550,800		view →

Free. We email you when criteria match. One-click unsubscribe in every email.

Custom alerts on filer activity · full feed access · daily intelligence · API. $1,500/mo. Pilots welcome.